Skip to main content
Top
Metadata
Title
Preclinical pharmacokinetic, antitumor and toxicity studies with CL-994 (N-acetyldinaline)
Authors
Brenda J. Foster
Lynne Jones
Richard Wiegand
Patrica M. LoRusso
Thomas H. Corbett
Publication date
01-09-1997
Publisher
Kluwer Academic Publishers
Published in
Investigational New Drugs / Issue 3/1997
Print ISSN: 0167-6997
Electronic ISSN: 1573-0646
DOI
https://doi.org/10.1023/A:1005846026398

Other articles of this Issue 3/1997

Investigational New Drugs 3/1997 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine